bioRxivImmunologyPreprint
FAM13A regulates KLRG1 expression and interferon gamma production of natural killer cells
N. Zeng, M. Theresine, C. Capelle, N. Patil, C. Masquelier, C. Davril, A. Baron, D. Coowar, X. Dervillez, A. Poli, C. Leonard, R. Balling, M. Ollert, J. Zimmer, F. Q. Hefeng
Abstract
The polymorphism of the gene FAM13A (family with sequence similarity 13, member A) is strongly linked to the risk of lung cancer and chronic obstructive pulmonary disease, which are among the leading causes of mortality and morbidity in lung-related diseases worldwide. However, the underlying molecular and cellular mechanisms through which FAM13A contributes to the pathogenesis of these diseases largely remain unclear. Here, using a Fam13a knock out (KO) mouse model, we showed that Fam13a depletion upregulated the expression of the terminal differentiation and inhibitory marker, KLRG1 (killer cell lectin-like receptor G1) in natural killer (NK) cells. NK cells from Fam13a-deficient mice showed impaired IFN-{gamma} production either against target tumor cells or following various cytokine cocktail stimulations. Furthermore, the number of lung metastases induced by B16F10 melanoma cells was increased in Fam13a-KO mice. Collectively, our data suggest a key role of FAM13A in regulating NK cell functions, indicating that the key lung-disease risk gene FAM13A might contribute to the pathogenesis of several lung diseases via regulating NK cells.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An IL-34-IGF-1 inflammatory axis fuels KRAS-mutant lung cancer progression
Jaroslav Žák, Hui Chen, … Judith A. Varner·bioRxiv·Jul 15, 2026
- A novel and potent MICA/B antibody is therapeutically effective in KRAS LKB1 mutant lung cancer models
Ryan R Kowash, Manoj Kumar Sabnani, … Esra A. Akbay·Journal for ImmunoTherapy of CancerPeer-reviewed·Jan 1, 2025
- CD39 defines a cytotoxic tumor-associated NK cell state responsive to NKG2A blockade in lung cancer
Clara Serger, Lucas Rebuffet, … Alfred Zippelius·bioRxiv·Aug 26, 2025
- NKG2D signaling regulates IL-17A-producing γδT cells to promote cancer progression
S. Curio, S. C. Edwards, … N. Guerra·bioRxiv·Aug 26, 2021
- FoxA1 and FoxA2 regulate growth and cellular identity in NKX2-1-positive lung adenocarcinoma
G. Orstad, G. Fort, … E. L. Snyder·bioRxiv·Jun 29, 2021
- The Aryl Hydrocarbon Receptor Controls IFNγ-Induced Immune Checkpoints PD-L1 and IDO via the JAK/STAT Pathway in Lung Adenocarcinoma
Megan Snyder, Zhongyan Wang, … David H. Sherr·The Journal of ImmunologyPeer-reviewed·Mar 1, 2025